Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SPIDIA

Financiado

Cerrado

Standardisation and improvement of generic pre analytical tools and procedures f...

Standardisation and improvement of generic pre analytical tools and procedures for in vitro diagnostics In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collection, handling, stabilisation and storage of biosamples which limits the reproducibility of... ver más

31/03/2013

QIAGEN GMBH

14M€

Presupuesto del proyecto: 14M€

Líder del proyecto

QIAGEN GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 12 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-03-31 No tenemos la información de la convocatoria

0% 65% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

QIAGEN GMBH

0.00€ | Lider

ERASMUS MC

N.D. | Participante

INT

N.D. | Participante

COMITE EUROPEEN DE NORMALISA...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

MARCADORES TEMPRANOS DE ALZHEIMER MEDIANTE LA... MARCADORES TEMPRANOS DE ALZHEIMER MEDIANTE LA COMBINACIÓN DE... 544K€ Cerrado

EQC2021-007365-P Plataforma de evaluación molecular proteica-genómica en comb... 1K€ Cerrado

ADDIT-CE Alzheimer's Disease Diagnostics Innovation and Translation t... 5M€ Cerrado

PID2021-127137OB-I00 PROTEOMICA Y MIRNOMICA DIRIGIDA PARA ABORDAR BIOMARCADORES D... 139K€ Cerrado

EQC2018-005332-P Detección precoz de enfermedades neurodegenerativas con inmu... 67K€ Cerrado

EUIN2013-51160 NEW BIOINFORMATICS TOOL TO INTEGRATE, UNDERSTAND AND EXPLOIT... 25K€ Cerrado

Líder del proyecto

QIAGEN GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 14M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collection, handling, stabilisation and storage of biosamples which limits the reproducibility of subsequent diagnoses, and (b) its scale is restrained to the cellular level. To address this first point, this IP, SPIDIA, built of clinicians, academics, tool and assay developers, aims to develop quality guidelines for molecular in vitro diagnostics and to standardize the pre-analytical workflow in related procedures. Regarding the second point, SPIDIA aims to develop modern pre-analytical tools for diagnostics improving the stabilisation, handling and study of free biomolecules within blood, plasma, serum, tissues and tumours. Recent discoveries have revealed that RNA, DNA or proteins, released from pathological sites, like tumour cells or Alzheimer’s disease (AD) brain lesions, into the blood or as a secondary blood based response to the disease can serve as biomarkers for early and reliable molecular diagnosis of such debilitating diseases. Further discoveries have shown that the cellular profiles of these molecules and structures in clinical samples can change during transport and storage thus making clinical assay results and pharmaceutical research unreliable or even impossible. It will therefore be a decisive prerequisite for future and current diagnostic assays to develop standards and new technologies, tools and devices that eliminate the human error in the pre-analytical steps of in vitro diagnostics. At this crucial moment in the development of molecular diagnostics, SPIDIA proposes an IP that reunites 7 private research companies (including 4 SMEs), 1 private research institute, 6 public research organisms, including universities, hospitals and biobanks, one management SME and an official European Standards Organisation. This strong consortium is balanced and empowered to maximise the impacts of in vitro diagnostics on human health.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores